Now in its third revision, the IWMF 2018 booklet explains the basic concepts of immunology and genetics as they pertain to WM.
The IWMF is pleased to announce the establishment of the IWMF Support Group-China. The newest IWMF Affiliate, under the leadership of Roger Yao, will be based in Shanghai.
The US Food and Drug Administration (FDA) has approved multiple strength versions of dosing tablets, which will replace the original 140 mg capsule.
This one-hour educational program on advances in research and quality of life issues for patients with WM, features Dr. Stephen Ansell of the Mayo Clinic, Rochester
Listen to Dr. Jorge Castillo of Dana-Farber Cancer Institute and Dr. Morie Gertz of Mayo Clinic discuss “Progress in the Treatment of WM”
If you haven’t already taken the survey, please do so by March 7. By doing so, you can help guide support and advocacy services for all of us.
Dr. Jorge Castillo’s (Dana-Farber Cancer Institute) presentation, “Treatment Options in WM,” was recorded and is now available for viewing.
The new non-live vaccine for shingles, Shingrix, has been approved by the FDA and the CDC in the US and by Health Canada for use in patients who are fifty and older.
With a population of just over four million, New Zealand is a small country in numbers of people, but not in land mass.
The IWMF has participated in the Global Patient Survey since 2012. It’s time again to participate & ensure that WM is represented.